Research programme: N-methylcantharidinimide - Aida Pharmaceuticals

Drug Profile

Research programme: N-methylcantharidinimide - Aida Pharmaceuticals

Latest Information Update: 28 May 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Aida Pharmaceuticals
  • Class Antineoplastics; Benzofurans; Imides; Polycyclic compounds; Small molecules
  • Mechanism of Action Enzyme inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 28 May 2008 No development reported - Preclinical for Cancer in China (Injection)
  • 03 Oct 2006 Preclinical trials in Cancer in China (Injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top